17 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 23 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Completed 17, Unknown 3, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Ectoparasitic Infestations: new trials by email Literature Review of Ectoparasitic Infestations trials Research Report on Ectoparasitic Infestations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Better Options for Lymphatic Filariasis Treatment MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies | Phase 3 | Recruiting | Medicines Development for Global Health | 5100 | 2026-09-28 | 2026-10-07 |
| Therapy for Scabies With Two Differently Concentrated Permethrin Creams 5% Permethrin Creme, 10% Permethrin Creme - Scabies | Phase 3 | Not yet recruiting | Infectopharm Arzneimittel GmbH | 220 | 2024-05-01 | 2024-04-23 |
| Sulfur vs. Different Regimes of Permethrin for Scabies Permethrin Solution, Sulfur - Scabies | Phase 3 | Completed | Damascus University | 250 | 2022-03-15 | 2024-05-02 |
| Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin) InfectoScab 5 % Creme, Permethrin 10 % Creme, Driponin 3 mg Tabletten - Scabies | Phase 3 | Unknown | Infectopharm Arzneimittel GmbH | 183 | 2021-06-11 | 2021-08-26 |
| Adjunctive Ivermectin Mass Drug Administration for Malaria Control Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases | Phase 3 | Unknown | London School of Hygiene and Tropical Medicine | 24000 | 2021-05-03 | 2022-02-24 |
| Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws | Phase 3 | Completed | Lihir Medical Centre | 20000 | 2018-10-01 | 2019-02-28 |
| A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies Permethrin Cream 5% - Scabies | Phase 3 | Completed | Saptalis Pharmaceuticals LLC | 126 | 2018-04-10 | 2020-10-23 |
| Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands Ivermectin, Permethrin 5%, Malathion Shampoo 0.5% - Scabies, Head Lice | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 118 | 2017-08-01 | 2019-06-14 |
| Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies Permethrin Cream, 5%, Elimite™ Cream (permethrin) 5% - Scabies | Phase 3 | Completed | Encube Ethicals Pvt. Ltd. | 254 | 2017-06-01 | 2019-03-26 |
| Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies spinosad topical suspension, 0.9%, Placebo - Scabies | Phase 3 | Completed | ParaPRO LLC | 280 | 2017-05-10 | 2021-05-21 |
| Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies spinosad topical suspension, 0.9%, Placebo - Scabies | Phase 3 | Completed | ParaPRO LLC | 291 | 2017-05-02 | 2021-05-19 |
| Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies. Permethrin Cream, 5%, Elimite - Scabies | Phase 3 | Completed | Mayne Pharma International Pty Ltd | 140 | 2016-11-01 | 2020-09-02 |
| Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults Ivermectin, Permethrin - Scabies | Phase 3 | Completed | University Hospital, Bordeaux | 1092 | 2016-01-19 | 2024-06-17 |
| A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies Permethrin - Scabies | Phase 3 | Completed | Dr. Reddy's Laboratories Limited | 250 | 2015-09-01 | 2016-10-14 |
| Efficacy and Safety Study for PIOLIN® Shampoo PIOLIN®, NEDAX - PEDICULOSIS | Phase 3 | Unknown | Phytopharm Consulting Brazil | 212 | 2014-07-01 | 2013-10-23 |
| Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Malathion gel 0.5%, Permethrin 1% rinse (Nix Crème) - Pediculosis | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 403 | 2009-08-01 | 2014-06-13 |
| Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Malathion gel 0.5%, Permethrin 1% rinse - Pediculosis | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 254 | 2009-08-01 | 2014-08-04 |
| Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice MALG (malathion) Treatment - Pediculosis | Phase 2 / Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 12 | 2008-09-01 | 2014-08-07 |
| Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Spinosad, Permethrin 1% - Pediculosis | Phase 3 | Completed | ParaPRO LLC | 558 | 2007-09-01 | 2012-10-11 |
| Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice MALG, Ovide (malathion) lotion 0.05%, Permethrin 1% - Lice Infestations | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 360 | 2005-12-01 | 2013-12-23 |
Showing 20 of 23. Sign in to see all of them.
Scabies (14) · Lice Infestations (9) · Elephantiasis, Filarial (3) · Strongyloidiasis (3) · Neglected Diseases (2) · Ancylostomiasis (1) · Malaria (1) · Malaria, Falciparum (1) · Parasitic Diseases (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Trachoma (1) · Yaws (1)
Infections (23) · Skin Diseases, Parasitic (23) · Skin and Connective Tissue Diseases (23) · Parasitic Diseases (22) · Skin Diseases (22) · Skin Diseases, Infectious (22) · Mite Infestations (14) · Filariasis (3) · Helminthiasis (3) · Hemic and Lymphatic Diseases (3) · Lymphatic Diseases (3) · Lymphedema (3) · Mosquito-Borne Diseases (3) · Nematode Infections (3)
Permethrin (8) · Ivermectin (5) · Malathion (3) · Suspensions (3) · spinosad (3) · Albendazole (2) · Azithromycin (1) · Diethylcarbamazine (1) · Sulfur (1) · Therapeutics (1) · coconut diethanolamide (1)
Sun Pharmaceutical Industries, Inc. (4) · ParaPRO LLC (3) · Infectopharm Arzneimittel GmbH (2) · London School of Hygiene and Tropical Medicine (2) · Damascus University (1) · Dr. Reddy's Laboratories Limited (1) · Encube Ethicals Pvt. Ltd. (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · Lihir Medical Centre (1) · Mayne Pharma International Pty Ltd (1) · Medical Entomology Centre (1) · Medicines Development for Global Health (1) · Phytopharm Consulting Brazil (1) · Saptalis Pharmaceuticals LLC (1) · Uniquest Pty Ltd (1)
United States (11) · El Salvador (2) · France (2) · Australia (1) · Brazil (1) · Fiji (1) · Germany (1) · Guadeloupe (1) · Guinea-Bissau (1) · Ireland (1) · Israel (1) · Panama (1) · Papua New Guinea (1) · Puerto Rico (1) · Solomon Islands (1)
Kerry W Mettert, MBA (2) · Anna R Last, MBChB PhD (1) · Ashis Patnaik, MD (1) · Bill Miller, MD (1) · Bruneau Giraudeau, Doctor (1) · Ian F Burgess (1) · Jerry Cottrell (1) · Lucy John, MD (1) · Phoevos Hughes, JD (1) · Prasanna Ganapathi, MD (1) · Pratik Kamani (1) · Shilpi Dhawan, MD (1)
PMID 17845167, PMID 20220184, PMID 30252856, PMID 37419638, PMID 39551062, PMID 41494769
2019 (1), 2023 (1)